Conference Agenda
Submit the form to access the Preliminary Agenda
Confirmed Speakers to Date
At Longevity Biotech 2025, we are assembling a world-class speaker faculty of researchers, drug developers, investors, and translational leaders advancing the science of aging. Early confirmed speakers include:
Ed Rudnic
COO and Head of R&D
Chief Scientific Officer
Lorna Harries
CEO
Robin Mansukhani
Raghav Sehgal
Principal Scientist
Adam Antebi
Director
Keith Comito
President
Anthony Sandrasagra
CSO
Chris Reading
SVP, Alzheimer’s Program
Benjamin LeCalvé
CEO
Michael Ringel
Chief Operating Officer
Elisabeth Roider
Founding Partner
Gil Blander
Founder
CSO
Mark Cockett
Patrick Burgermeister
Partner
Andrei Gudkov
Professor
Jack Scannell
CEO
Vera Gorbunova
Co-director
Aurora Griffin
Managing Partner Investor Relations Lead
Kristen Fortney
CEO
Janine Sengstack
CSO
Sebastian Brunemeier
Co-Founder & General Partner
Andrea Maier
Professor in Medicine and Functional Ageing
Nina Horowtiz
CEO
Joshua Herring
President & CEO
Tanya Lama
Assistant Professor
Ethan Sarnoski
Senior Program Advisor
Alexander Fleming
Founder and President
Dylan V. Livingston
Founder & CEO
Ali Siam
Chief Business Officer
Kotb Abdelmohsen
Staff Scientist
Yuta Lee
CEO
Holger Heyn
CSO
Paul M. Ridker
Director of the Center for Cardiovascular Disease Prevention
Eric Morgen
COO
Andy Lee
CBO & Co-founder
Jesse Poganik
Instructor
Andrea Cipriano
Instructor
Judith Altarejos
Senior Director
Monty Montano
Editor-in-Chief, Aging Cell
Sessions
The Fundamental Biology of Aging
Preclinical Discovery & Mechanistic Insights
Drug Repurposing & Adjacent Therapeutics
Clinical Trials & Readouts
Regulatory Landscape
Market Landscape & Investment Strategy
